• jump to the main content
  • jump to the bottom of the page
  • News
  • Podcasts
  • Activities
  • Location and contact
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
Idibaps logo
Search
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Healthcare
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Patients and companions
    • Assistive Devices
    • Organizational structure
  • Research
    • Home
    • About research
    • Areas and Programmes
    • Core Facilities
    • Knowledge and Technology Transfer
    • Work at Idibaps
  • Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • Patients and companions
  • About the Clinic
  • News
  • Podcasts
  • Activities
  • Location and contact
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
Navigation thread
  • Home
  • Organizational structure
  • Unit of Neuroinmunología y Esclerosis Múltiple
  • News
  • Unit of Neuroinmunología y Esclerosis Múltiple

Unit News from Neuroinmunología y Esclerosis Múltiple

Clínic Barcelona
Clínic Barcelona
November 19 2024 2024-11-19

Nine researchers from the Clínic-IDIBAPS among the most highly cited researchers according to Clarivate Analytics

Clarivate Analytics has published its ranking of the most cited researchers in the world, the Highly Cited Researchers, which identifies the most inf1

Clínic Barcelona
Clínic Barcelona
May 2 2024 2024-05-02

Persistent symptoms after treatment in a type of autoimmune encephalitis are characterized

A study coordinated by the Clínic-IDIBAPS and published in The Lancet Neurology, has examined the symptoms experienced by patients with anti-LGI1 enc1

Clínic Barcelona
Clínic Barcelona
April 29 2024 2024-04-30

The Clínic hospital , a pioneering centre in Spain in offering non-pharmacological therapies for neurodegenerative diseases

With the expansion of the Day Hospital for Neurodegenerative Diseases at the Clínic Barcelona Hospital, it will be possible to receive over 15,000 vi1

Clínic Barcelona
Clínic Barcelona
November 15 2023 2023-11-15

Seven researchers from the Hospital Clínic-IDIBAPS among the most highly cited researchers according to Clarivate Analytics

Clarivate Analytics has published its ranking of the most cited researchers in the world, the Highly Cited Researchers, which identifies the most inf1

Clínic Barcelona
Clínic Barcelona
June 28 2023 2023-06-29

First genetic marker for Multiple Sclerosis severity identified

This finding, published today in the journal Nature, opens the door to the development of new treatments to prevent long-term disability.

Clínic Barcelona
Clínic Barcelona
February 21 2023 2023-02-22

Diagnostic criteria are established for MOGAD, a neurological disease that can be confused with multiple sclerosis

Researchers at the Hospital Clínic-IDIBAPS participated in a study published in Lancet Neurology, which establishes the first diagnostic criteria for1

Clínic Barcelona
Clínic Barcelona
November 15 2022 2022-11-17

Eight researchers from the Hospital Clínic-IDIBAPS and the University of Barcelona in the ranking of the best in the world

The list, published by Clarivate Analytics, identifies the most influential experts, who are among the 1% most highly cited in their speciality in di1

Clínic Barcelona
Clínic Barcelona
June 7 2022 2022-06-07

The Neutroimmunology-Multiple Sclerosis Unit of the Clínic-IDIBAPS seeks to collaborate with other hospitals to carry out three clinical trials in autoimmune encephalitis

Next Wednesday, June 22, a meeting will be held to recount the diseases and present the clinical trials.

Clínic Barcelona
Clínic Barcelona
February 16 2022 2022-02-17

What is the relationship between infection with the Epstein-Barr virus and multiple sclerosis?

A Harvard University study of 10 million people finds that 97% of people with multiple sclerosis have been infected by the Epstein-Barr virus. This d1

Clínic Barcelona
Clínic Barcelona
February 26 2021 2021-02-26

What is the impact of COVID-19 on Multiple Sclerosis patients?

The Hospital Clínic de Barcelona’s Multiple Sclerosis and Neuroimmunology Department has conducted a study to ascertain the impact of COVID-19 on Mul1

Subscribe to the Newsletter of Clínic

Receive the latest news from our institution directly to your email.

Thanks for your subscription!

We have received your information. Check your inbox, in a few moments you will receive a confirmation email.

An error has occurred and we have not been able to send your data, please try again later.
  • Healthcare
    Healthcare
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Patients and companions
    • Work with Clínic
  • Research
    Research
    • Home
    • About research
    • Areas and Programmes
    • Core Facilities
    • Work with IDIBAPS
  • Teaching
    Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • Cookies policy
  • Profile of the contracting party
  • Legal Notice
  • Data protection
  • Transparency portal
  • Privacy policy
  • Complaint channel
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
© Clínic Barcelona 2025